000			01985 a2200541 4500
005			20250517185617.0
264		0	_c20181126
008			201811s 0 0 eng d
022			_a1097-6787
024	7		_a10.1016/j.jaad.2017.11.031 _2doi
040			_aNLM _beng _cNLM
100	1		_aTran, Duy Cong
245	0	0	_aAn exploratory open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas. _h[electronic resource]
260			_bJournal of the American Academy of Dermatology _c05 2018
300			_a1011-1013.e3 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAminopyridines _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBiphenyl Compounds _xadministration & dosage
650	0	4	_aCarcinoma, Basal Cell _xdrug therapy
650	0	4	_aCohort Studies
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMiddle Aged
650	0	4	_aMorpholines _xadministration & dosage
650	0	4	_aNeoplasm Invasiveness _xpathology
650	0	4	_aNeoplasm Staging
650	0	4	_aPrognosis
650	0	4	_aProspective Studies
650	0	4	_aPyridines _xadministration & dosage
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
700	1		_aMoffat, Ann
700	1		_aBrotherton, Richard
700	1		_aPague, Alana
700	1		_aZhu, Gefei Alex
700	1		_aChang, Anne Lynn S
773	0		_tJournal of the American Academy of Dermatology _gvol. 78 _gno. 5 _gp. 1011-1013.e3
856	4	0	_uhttps://doi.org/10.1016/j.jaad.2017.11.031 _zAvailable from publisher's website
999			_c27825141 _d27825141